本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fate Therapeutics Inc

1.16
-0.0750-6.10%
成交量:90.80萬
成交額:106.39萬
市值:1.34億
市盈率:-1.00
高:1.23
開:1.22
低:1.14
收:1.23
52周最高:1.94
52周最低:0.6611
股本:1.16億
流通股本:1.01億
量比:0.54
換手率:0.90%
股息:- -
股息率:- -
每股收益(TTM):-1.1500
每股收益(LYR):-1.1500
淨資產收益率:-51.84%
總資產收益率:-24.12%
市淨率:0.65
市盈率(LYR):-1.00

資料載入中...

2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/26

SEC問詢函

Form CORRESP - Correspondence
2024/03/25

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/25

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities